Kaufman D B, Platt J L, Rabe F L, Dunn D L, Bach F H, Sutherland D E
Department of Surgery, University of Minnesota Medical School, Minneapolis 55455.
J Exp Med. 1990 Jul 1;172(1):291-302. doi: 10.1084/jem.172.1.291.
The high rate of persistent hyperglycemia, termed primary nonfunction, after islet allotransplantation in C57BL/6 mice recipients of B10.BR strain islets, as compared with B10.BR recipients of C57BL/6 islets, led to a series of experiments to determine whether islet allograft primary nonfunction was attributable to technical aspects of the transplant procedure or whether it was a consequence of alloimmunity. Primary nonfunction was prevented by systemic pharmacologic immunosuppression of the host with cyclosporine. Selective immunodepletion of host CD4+ and CD8+ T lymphocytes significantly extended the time of classic rejection but did not significantly affect the rate of primary nonfunction. However, modulation of macrophages by administration to the host of silica completely abolished primary nonfunction. These observations, in conjunction with the immunohistological findings of intense macrophage infiltration in islet allografts from recipients exhibiting persistent post-transplant hyperglycemia, support the hypothesis that primary nonfunction results from a cell-mediated host-immune response of rapid onset that is dependent on macrophages or macrophage byproducts as the main effectors.
在接受B10.BR品系胰岛的C57BL/6小鼠受体中,胰岛同种异体移植后持续性高血糖发生率很高,这被称为原发性无功能,与接受C57BL/6胰岛的B10.BR受体相比,这引发了一系列实验,以确定胰岛同种异体移植原发性无功能是归因于移植手术的技术方面,还是同种免疫的结果。用环孢素对宿主进行全身药理学免疫抑制可预防原发性无功能。选择性免疫清除宿主CD4 +和CD8 + T淋巴细胞可显著延长经典排斥反应的时间,但对原发性无功能的发生率没有显著影响。然而,通过向宿主施用二氧化硅来调节巨噬细胞可完全消除原发性无功能。这些观察结果,结合对移植后持续高血糖的受体的胰岛同种异体移植中巨噬细胞强烈浸润的免疫组织学发现,支持了原发性无功能是由快速发作的细胞介导的宿主免疫反应导致的这一假说,该反应依赖巨噬细胞或巨噬细胞副产物作为主要效应物。